Cited by 173Atrial Fibrillation Management and OutcomesDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)

Open access
Fatemi, Omid, Yuriditsky, Eugene, Tsioufis, Costas, Tsachris, Demetrios, Morgan, Timothy, Basile, Jan, Bigger, Thomas, Cushman, William +4 more·2014·The American Journal of Cardiology

Abstract

Atrial fibrillation (AF) is prevalent in patients with type 2 diabetes mellitus (DM) and is associated with markers of poor glycemic control; however, the impact of glycemic control on incident AF and outcomes is unknown. The aims of this study were to prospectively evaluate if intensive glycemic control in patients with DM affects incident AF and to evaluate morbidity and mortality in patients with DM and incident AF. A total of 10,082 patients with DM from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) cohort were studied in a randomized, double-blind fashion. Participants were randomized to an intensive therapeutic strategy targeting a glycated hemoglobin level of <6.0% or a standard strategy targeting a glycated hemoglobin level of 7.0% to 7.9%. Incident AF occurred in 159 patients (1.58%) over the follow-up period, at a rate of 5.9 per 1,000 patient-years in the intensive-therapy group and a rate of 6.37 per 1,000 patient-years in the standard-therapy group (p = 0.52). In a multivariate model, predictors of incident AF were age, weight, diastolic blood pressure, heart rate, and heart failure history. Patients with DM and new-onset AF had a hazard ratio of 2.65 for all-cause mortality (95% confidence interval 1.8 to 3.86, p <0.0001), a hazard ratio of 2.1 for myocardial infarction (95% confidence interval 1.33 to 3.31, p = 0.0015), and a hazard ratio of 3.80 for the development of heart failure (95% confidence interval 2.48 to 5.84, p <0.0001). In conclusion, intensive glycemic control did not affect the rate of new-onset AF. Patients with DM and incident AF had an increased risk for morbidity and mortality compared with those without AF.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2014.07.045

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 28 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [19]Benjamin EJ Levy D Vaziri SM D’Agostino R Belanger AJ Wolf PA Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA 1994 271 840 844 8114238

Cited by

Sorted by citations

Authors
Fatemi, O., Yuriditsky, E., Tsioufis, C., Tsachris, D., Morgan, T., Basile, J., Bigger, T., Cushman, W., Goff, D., Soliman, E. Z., Thomas, A., & Papademetriou, V.
Affiliations
  • MedStar Washington Hospital Center (US)
  • National and Kapodistrian University of Athens (GR)
  • Atrium Health Wake Forest Baptist (US)
  • Medical University of South Carolina (US)
  • Columbia University Irving Medical Center (US)
  • University of Tennessee Health Science Center (US)
  • Colorado School of Public Health (US)
  • Henry Ford Health (US)
  • Georgetown University (US)
Corresponding author
Yuriditsky, Eugene
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2014-10
Volume
114
Issue
8
Pages
1217-1222
ISSN
0002-9149 (ISSN-L)
OpenAlex
W2020081546
Cited by
173
References
28
Citations by year
2026: 8 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 18 · 2021: 21 · 2020: 20 · 2019: 15 · 2018: 17 · 2017: 14 · 2016: 13 · 2015: 9
FWCI
8.22
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (n01hc95184-24-0-1, n01hc95182-23-0-1)
  • National Heart, Lung, and Blood Institute (N01 HC095184, N01 HC095182, Y01 HC001010, Y01 HC009035)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
atrial fibrillation, type 2 diabetes, tight glycemic control, HbA1c, cardiovascular outcomes, all-cause mortality, myocardial infarction, heart failure, atrial fibrillation risk factors, ACCORD trial
MeSH terms
Adult, Aged, Atrial Fibrillation, Blood Glucose, Canada, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Double-Blind Method, Electrocardiography, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Prospective Studies, Risk Factors, United States, Incidence, Prevalence, Survival Rate, Glycemic Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review